|
Cohance Lifesciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
20497.95 Cr.
|
P/BV
|
11.99
|
Book Value (Rs.)
|
44.68
|
|
52 Week High/Low (Rs.)
|
1328/521
|
FV/ML
|
1/1
|
P/E(X)
|
76.52
|
|
Bookclosure
|
09/08/2024
|
EPS (Rs.)
|
7.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 10.52 | 11.80 | 16.16 | 17.83 | 14.23 |
| Diluted EPS (Rs.) | 10.45 | 11.80 | 16.16 | 17.83 | 14.23 |
| Cash EPS (Rs.) | 13.44 | 13.94 | 18.03 | 17.75 | 13.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 66.64 | 80.56 | 68.16 | 59.99 | 46.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 66.64 | 80.56 | 68.16 | 59.99 | 46.39 |
| Revenue From Operations / Share (Rs.) | 47.04 | 41.30 | 52.65 | 51.86 | 39.66 |
| PBDIT / Share (Rs.) | 17.04 | 18.37 | 24.08 | 26.39 | 17.86 |
| PBIT / Share (Rs.) | 13.99 | 16.23 | 22.20 | 24.85 | 16.62 |
| PBT / Share (Rs.) | 13.51 | 15.94 | 21.99 | 24.61 | 16.26 |
| Net Profit / Share (Rs.) | 10.40 | 11.80 | 16.16 | 16.21 | 12.12 |
| NP After MI And SOA / Share (Rs.) | 10.52 | 11.80 | 16.16 | 17.83 | 14.23 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 36.21 | 44.48 | 45.72 | 50.88 | 45.03 |
| PBIT Margin (%) | 29.74 | 39.29 | 42.16 | 47.92 | 41.90 |
| PBT Margin (%) | 28.71 | 38.58 | 41.76 | 47.45 | 40.99 |
| Net Profit Margin (%) | 22.10 | 28.56 | 30.68 | 31.25 | 30.56 |
| NP After MI And SOA Margin (%) | 22.36 | 28.56 | 30.68 | 34.37 | 35.88 |
| Return on Networth / Equity (%) | 15.78 | 14.64 | 23.70 | 29.71 | 30.68 |
| Return on Capital Employeed (%) | 13.36 | 19.24 | 31.27 | 39.07 | 33.71 |
| Return On Assets (%) | 8.83 | 13.32 | 20.92 | 24.80 | 24.57 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 |
| Total Debt / Equity (X) | 0.04 | 0.01 | 0.04 | 0.06 | 0.11 |
| Asset Turnover Ratio (%) | 0.45 | 0.49 | 0.70 | 0.80 | 0.79 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.43 | 11.82 | 6.37 | 5.36 | 2.57 |
| Quick Ratio (X) | 1.98 | 9.65 | 4.40 | 4.02 | 1.66 |
| Inventory Turnover Ratio (X) | 6.02 | 3.87 | 1.44 | 1.90 | 1.65 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 49.51 | 22.43 | 7.02 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 44.36 | 20.65 | 6.46 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 50.49 | 77.57 | 92.98 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 55.64 | 79.35 | 93.54 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 35.12 | 62.77 | 112.74 | 107.82 | 49.73 |
| Interest Coverage Ratio (Post Tax) (%) | 22.44 | 41.30 | 76.66 | 67.23 | 34.75 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 29662.03 | 17211.94 | 12039.36 | 15779.11 | 12742.73 |
| EV / Net Operating Revenue (X) | 24.77 | 16.37 | 8.98 | 11.95 | 12.62 |
| EV / EBITDA (X) | 68.38 | 36.80 | 19.64 | 23.49 | 28.02 |
| MarketCap / Net Operating Revenue (X) | 24.66 | 16.38 | 8.98 | 11.92 | 12.49 |
| Retention Ratios (%) | 0.00 | 0.00 | 50.48 | 77.56 | 92.97 |
| Price / BV (X) | 17.40 | 8.40 | 6.93 | 10.30 | 10.68 |
| Price / Net Operating Revenue (X) | 24.66 | 16.38 | 8.98 | 11.92 | 12.49 |
| EarningsYield | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 |
